Back to trial details

Intake questionnaire

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Applying to Henry Ford Wyandotte Hospital · Wyandotte, Michigan

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Recurrent Lung Non-Small Cell Carcinoma?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Wyandotte for study visits?